Alitretinoin for Severe Chronic Hand Eczema

  title={Alitretinoin for Severe Chronic Hand Eczema},
  author={Mr Mark Rodgers and Susan C. Griffin and Mike Paulden and Russell Slack and Steven Duffy and John R Ingram and Nerys F Woolacott and Mark John Sculpher},
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of alitretinoin (Basilea Pharmaceuticals Ltd, Basel, Switzerland) to submit evidence for the clinical and cost effectiveness of this drug for the treatment of patients with severe chronic hand eczema (CHE), as part of the Institute’s single technology appraisal (STA) process. The Centre for Reviews and Dissemination and the Centre for Health Economics at the University of York were commissioned to act as… CONTINUE READING
29 Citations
11 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 29 extracted citations


Publications referenced by this paper.
Showing 1-10 of 11 references

Re-treatment study of alitretinoin (9-cis retinoic acid) in severe chronic hand eczema refractory to topical treatment [abstract no. P-280

  • T Ruzicka, M Lahfa, CH Lynde
  • Congress of the European Academy of Dermatology…
  • 2007
Highly Influential
3 Excerpts

The treatment of atopic dermatitis with systemic immunosuppresive agents

  • A Akhaven, D. Rudikoff
  • Clin Dermatol
  • 2003
1 Excerpt

Toctino 10 mg and 30 mg soft capsules . SPC . electronic Medicines Compendium ( eMC ) , 2008 [ online ] Eczema ( chronic ) alitretinoin : manufacturer submission [ online ]

  • T Ruzicka, CW Lynde, Jemec GBE
  • 2003

Similar Papers

Loading similar papers…